LPL Financial
ASND icon

LPL Financial’s Ascendis Pharma A/S ASND Stock Holding History

LPL Financial’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.83M Sell
14,345
-834
-5% -$195K ﹤0.01% 3051
2026
Q1 		$3.47M Buy
15,179
+1,048
+7% +$235K ﹤0.01% 2962
2025
Q4 		$3.01M Buy
14,131
+4,277
+43% +$883K ﹤0.01% 3012
2025
Q3 		$1.96M Buy
9,854
+2,587
+36% +$483K ﹤0.01% 3331
2025
Q2 		$1.25M Buy
7,267
+3,787
+109% +$617K ﹤0.01% 3544
2025
Q1 		$542K Sell
3,480
-719
-17% -$103K ﹤0.01% 4100
2024
Q4 		$578K Buy
4,199
+1,577
+60% +$207K ﹤0.01% 3966
2024
Q3 		$391K Sell
2,622
-252
-9% -$34K ﹤0.01% 4214
2024
Q2 		$392K Buy
2,874
+296
+11% +$40.3K ﹤0.01% 4066
2024
Q1 		$390K Sell
2,578
-276
-10% -$39.4K ﹤0.01% 3989
2023
Q4 		$359K Sell
2,854
-382
-12% -$38.1K ﹤0.01% 3940
2023
Q3 		$303K Sell
3,236
-597
-16% -$55.9K ﹤0.01% 3914
2023
Q2 		$342K Buy
+3,833
New +$334K ﹤0.01% 3739
2023
Q1 		– Sell
-1,736
Closed -$212K – 4488
2022
Q4 		$212K Buy
+1,736
New +$202K ﹤0.01% 3931
2022
Q3 		– Sell
-2,288
Closed -$213K – 4419
2022
Q2 		$213K Sell
2,288
-55
-2% -$5.18K ﹤0.01% 3893
2022
Q1 		$275K Sell
2,343
-393
-14% -$45.5K ﹤0.01% 3629
2021
Q4 		$368K Buy
2,736
+555
+25% +$82.6K ﹤0.01% 3539
2021
Q3 		$348K Sell
2,181
-117
-5% -$16K ﹤0.01% 3528
2021
Q2 		$302K Buy
2,298
+25
+1% +$3.33K ﹤0.01% 3580
2021
Q1 		$293K Sell
2,273
-50
-2% -$7.6K ﹤0.01% 3478
2020
Q4 		$387K Sell
2,323
-206
-8% -$34.1K ﹤0.01% 2979
2020
Q3 		$390K Buy
2,529
+21
+0.8% +$3.02K ﹤0.01% 2683
2020
Q2 		$371K Sell
2,508
-10
-0.4% -$1.37K ﹤0.01% 2667
2020
Q1 		$284K Buy
+2,518
New +$327K ﹤0.01% 2541
2019
Q3 		– Sell
-2,233
Closed -$257K – 3295
2019
Q2 		$257K Buy
2,233
+131
+6% +$15.7K ﹤0.01% 2827
2019
Q1 		$247K Buy
+2,102
New +$184K ﹤0.01% 2785

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

LPL Financial's ASND Position: Q2 2026 in Review

LPL Financial reduced its Ascendis Pharma A/S (ASND) stake by 5.5% in Q2 2026, selling an estimated $195K and leaving 14,345 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #3051.

LPL Financial first reported a position in ASND in Q1 2019 and has held it in 26 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • LPL Financial held 14,345 shares of Ascendis Pharma A/S worth $3.83M as of Q2 2026.
  • LPL Financial sold 834 Ascendis Pharma A/S shares in Q2 2026, an estimated $195K.
  • Ascendis Pharma A/S made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3051 holding.
  • LPL Financial first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 26 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.